No centers match
Try a different search term
1 SAMHSA-listed treatment center in Burlington, Vermont. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Burlington.
Burlington, Vermont has 1 SAMHSA-verified addiction treatment center offering 1 dual diagnosis, 1 outpatient. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Outpatient programs allow Burlington residents to receive treatment while maintaining their daily responsibilities. Sessions are typically scheduled 3-5 days per week, making it possible to continue working or attending school.
Treatment centers in Burlington accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Adolescents in Burlington access addiction treatment through pathways distinct from adult care: school-based counselor referrals, pediatrician referrals, juvenile justice system connections, and family-initiated admissions. The federally funded Adolescent Community Reinforcement Approach (A-CRA), Multidimensional Family Therapy (MDFT), and structured family-based interventions are first-line evidence-based options. Adult treatment settings are clinically inappropriate for adolescents and most Vermont jurisdictions require age-appropriate licensed providers.
Relapse is statistically common in addiction recovery and does not signal treatment failure for Burlington patients. National data shows roughly 40-60% of patients experience at least one relapse within the first year post-treatment, paralleling chronic-disease relapse rates (hypertension, asthma, diabetes). Treatment models increasingly frame addiction as a chronic condition requiring long-term management rather than acute episodes with cures. Relapse response should be immediate re-engagement with treatment, not discharge from the recovery community.
Insurance coverage for addiction treatment in Burlington is governed by the Mental Health Parity and Addiction Equity Act (MHPAEA), which requires plans that cover substance-use treatment to do so at parity with medical/surgical benefits. In practice: if your plan covers a hospitalization for a heart condition, it must cover residential addiction treatment under comparable cost-sharing, day limits, and authorization requirements. The ACA further classifies substance-use disorder treatment as an Essential Health Benefit, meaning individual and small-group marketplace plans must include this coverage.
Patients arriving at Burlington residential facilities should expect a medical evaluation within hours of admission: vital signs, withdrawal-symptom assessment using validated scales (CIWA for alcohol, COWS for opioids), medication reconciliation with the patient's prescribing providers, and physical examination by nursing or physician staff. Medical stabilization takes priority over therapeutic programming during this early phase — patients in active withdrawal aren't expected to engage in group therapy until stabilization is achieved.
Severe mental illness — schizophrenia, schizoaffective disorder, severe bipolar — requires specialized clinical capacity that not every Burlington addiction-treatment program maintains. Patients with active psychotic symptoms, recent psychiatric hospitalization, or complex psychiatric medication regimens may need facilities with on-site psychiatric providers, integrated mental-health-and-addiction protocols, and connections to outpatient psychiatric continuity. Admissions screening should explicitly address this fit before the patient commits.
Addiction treatment access in Burlington, Vermont, follows the same standards that govern the broader U.S. healthcare system: state licensing for residential and detox facilities, ASAM criteria-based clinical placement, parity-protected insurance coverage under federal law, and integrated mental-health support for the substantial fraction of patients presenting with co-occurring conditions. Burlington residents typically begin the treatment-seeking process with a verification call to assess clinical severity and insurance benefits, followed by ASAM-aligned placement into the appropriate level of care.
ASAM levels of care available to Burlington residents range across the standard continuum: Level 1 outpatient counseling (less than 9 hours/week of structured programming), Level 2.1 intensive outpatient (9+ hours/week), Level 2.5 partial hospitalization (20+ hours/week), Level 3.1 clinically managed low-intensity residential, Level 3.5 medium-intensity residential, Level 3.7 medically monitored intensive inpatient, and Level 4 medically managed intensive inpatient (typically hospital-based detox for the most severe withdrawal presentations). Movement between levels follows clinical criteria, not calendar dates — patients step up when current intensity proves insufficient and step down as they stabilize.